Camp4 Therapeutics (CAMP) FCF Margin (2024 - 2026)
Camp4 Therapeutics (CAMP) posted FCF Margin of 848.61% for Q1 2026, down 147.27% sequentially from 1795.11% in Q4 2025, and up 81643.0% YoY from N/an in Q1 2025.
Camp4 Therapeutics (CAMP) FCF Margin (2024 - 2026) Analysis & Trends
Camp4 Therapeutics has reported FCF Margin for 3 years, with the latest figure at 848.61% in Q1 2026.
- Quarterly FCF Margin rose 81643.0% year-over-year to 848.61% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 674.3% (up 257040.0% YoY) and the FY2025 annual result came in at 852.83%, up 620284.0% from the prior year.
- FCF Margin slipped to 848.61% in Q1 2026 per CAMP's latest filing, from 1795.11% in the prior quarter.
- Over five years, FCF Margin peaked at 1795.11% in Q4 2025 and troughed at 1771.63% in Q4 2024.
- A 3-year average of 767.48% and a median of 1126.88% in 2025 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2025 and 2026: FCF Margin soared 356674 bps in 2025, then jumped 81643 bps in 2026.
- Over 3 years, FCF Margin stood at 1771.63% in 2024, then soared by 201 bps to 1795.11% in 2025, then plunged by 147 bps to 848.61% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 848.61%, 1795.11%, and 1405.16% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Camp4 Therapeutics | 282.48 Mn | 282.48 Mn | - | -730.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -730.64% |
| Mar 31, 2026 | -848.61% |
| Dec 31, 2025 | 1,795.11% |
| Sep 30, 2025 | -1,405.16% |
| Jun 30, 2025 | -709.55% |
| Mar 31, 2025 | -1,665.03% |
| Dec 31, 2024 | -1,771.63% |